Secondly, while our current study focused on systemic and vascular responses to repeated tau-PFFs exposure, further work is needed to clarify whether these changes translate into functional motor impairments relevant to PSP. The gene discussed is MAPT; the disease is supranuclear palsy, progressive, 1.